In less than five years, the value of this market is expected to exceed $11 billion.
Recent healthcare and political changes are opening the door for medical device companies.
Foreign companies can capitalize on offering their products in Asia but must be prepared to do so at a lower price.
The rise in cancer cases has led device companies to form partnerships to distribute their products in the region.
Devices that help treat respiratory problems are in high demand.
Burmese consumers are willing to pay more for healthcare products from the United States and Europe.
The country can’t ignore the fact that Asia is the future of medtech growth.
With a growing population and income, residents in Vietnam have more money to spend on healthcare, and improvements to hospitals are increasing the opportunities for medtech companies.
A lack of quality, locally made products opens the door for Western device companies.
How are you protecting your IP and keeping talent from going overseas?